Extracellular proteases are key mediators of Staphylococcus aureus virulence via the global modulation of virulence‐determinant stability

Staphylococcus aureus is a highly virulent and successful pathogen that causes a diverse array of diseases. Recently, an increase of severe infections in healthy subjects has been observed, caused by community‐associated methicillin‐resistant S. aureus (CA‐MRSA). The reason for enhanced CA‐MRSA viru...

Full description

Saved in:
Bibliographic Details
Published inMicrobiologyOpen (Weinheim) Vol. 2; no. 1; pp. 18 - 34
Main Authors Kolar, Stacey L., Antonio Ibarra, J., Rivera, Frances E., Mootz, Joe M., Davenport, Jessica E., Stevens, Stanley M., Horswill, Alexander R., Shaw, Lindsey N.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.02.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Staphylococcus aureus is a highly virulent and successful pathogen that causes a diverse array of diseases. Recently, an increase of severe infections in healthy subjects has been observed, caused by community‐associated methicillin‐resistant S. aureus (CA‐MRSA). The reason for enhanced CA‐MRSA virulence is unclear; however, work suggests that it results from hypersecretion of agr‐regulated toxins, including secreted proteases. In this study, we explore the contribution of exo‐proteases to CA‐MRSA pathogenesis using a mutant lacking all 10 enzymes. We show that they are required for growth in peptide‐rich environments, serum, in the presence of antimicrobial peptides (AMPs), and in human blood. We also reveal that extracellular proteases are important for resisting phagocytosis by human leukocytes. Using murine infection models, we reveal contrasting roles for the proteases in morbidity and mortality. Upon exo‐protease deletion, we observed decreases in abscess formation, and impairment during organ invasion. In contrast, we observed hypervirulence of the protease‐null strain in the context of mortality. This dichotomy is explained by proteomic analyses, which demonstrates exo‐proteases to be key mediators of virulence‐determinant stability. Specifically, increased abundance of both secreted (e.g. α‐toxin, Psms, LukAB, LukE, PVL, Sbi, γ‐hemolysin) and surface‐associated (e.g. ClfA+B, FnbA+B, IsdA, Spa) proteins was observed upon protease deletion. Collectively, our findings provide a unique insight into the progression of CA‐MRSA infections, and the role of secreted proteolytic enzymes. We show here that secreted proteases are major regulators of Staphylococcus aureus infections. They function by not only cleaving self‐derived virulence determinants to control the progression of infection, but possess their own, innate, virulence affecting properties as well. As such, they can be consider key factors in the control of S. aureus disease progression.
AbstractList Staphylococcus aureus is a highly virulent and successful pathogen that causes a diverse array of diseases. Recently, an increase of severe infections in healthy subjects has been observed, caused by community-associated methicillin-resistant S. aureus (CA-MRSA). The reason for enhanced CA-MRSA virulence is unclear; however, work suggests that it results from hypersecretion of agr-regulated toxins, including secreted proteases. In this study, we explore the contribution of exo-proteases to CA-MRSA pathogenesis using a mutant lacking all 10 enzymes. We show that they are required for growth in peptide-rich environments, serum, in the presence of antimicrobial peptides (AMPs), and in human blood. We also reveal that extracellular proteases are important for resisting phagocytosis by human leukocytes. Using murine infection models, we reveal contrasting roles for the proteases in morbidity and mortality. Upon exo-protease deletion, we observed decreases in abscess formation, and impairment during organ invasion. In contrast, we observed hypervirulence of the protease-null strain in the context of mortality. This dichotomy is explained by proteomic analyses, which demonstrates exo-proteases to be key mediators of virulence-determinant stability. Specifically, increased abundance of both secreted (e.g. α-toxin, Psms, LukAB, LukE, PVL, Sbi, γ-hemolysin) and surface-associated (e.g. ClfA+B, FnbA+B, IsdA, Spa) proteins was observed upon protease deletion. Collectively, our findings provide a unique insight into the progression of CA-MRSA infections, and the role of secreted proteolytic enzymes.Staphylococcus aureus is a highly virulent and successful pathogen that causes a diverse array of diseases. Recently, an increase of severe infections in healthy subjects has been observed, caused by community-associated methicillin-resistant S. aureus (CA-MRSA). The reason for enhanced CA-MRSA virulence is unclear; however, work suggests that it results from hypersecretion of agr-regulated toxins, including secreted proteases. In this study, we explore the contribution of exo-proteases to CA-MRSA pathogenesis using a mutant lacking all 10 enzymes. We show that they are required for growth in peptide-rich environments, serum, in the presence of antimicrobial peptides (AMPs), and in human blood. We also reveal that extracellular proteases are important for resisting phagocytosis by human leukocytes. Using murine infection models, we reveal contrasting roles for the proteases in morbidity and mortality. Upon exo-protease deletion, we observed decreases in abscess formation, and impairment during organ invasion. In contrast, we observed hypervirulence of the protease-null strain in the context of mortality. This dichotomy is explained by proteomic analyses, which demonstrates exo-proteases to be key mediators of virulence-determinant stability. Specifically, increased abundance of both secreted (e.g. α-toxin, Psms, LukAB, LukE, PVL, Sbi, γ-hemolysin) and surface-associated (e.g. ClfA+B, FnbA+B, IsdA, Spa) proteins was observed upon protease deletion. Collectively, our findings provide a unique insight into the progression of CA-MRSA infections, and the role of secreted proteolytic enzymes.
Staphylococcus aureus is a highly virulent and successful pathogen that causes a diverse array of diseases. Recently, an increase of severe infections in healthy subjects has been observed, caused by community‐associated methicillin‐resistant S. aureus (CA‐MRSA). The reason for enhanced CA‐MRSA virulence is unclear; however, work suggests that it results from hypersecretion of agr‐regulated toxins, including secreted proteases. In this study, we explore the contribution of exo‐proteases to CA‐MRSA pathogenesis using a mutant lacking all 10 enzymes. We show that they are required for growth in peptide‐rich environments, serum, in the presence of antimicrobial peptides (AMPs), and in human blood. We also reveal that extracellular proteases are important for resisting phagocytosis by human leukocytes. Using murine infection models, we reveal contrasting roles for the proteases in morbidity and mortality. Upon exo‐protease deletion, we observed decreases in abscess formation, and impairment during organ invasion. In contrast, we observed hypervirulence of the protease‐null strain in the context of mortality. This dichotomy is explained by proteomic analyses, which demonstrates exo‐proteases to be key mediators of virulence‐determinant stability. Specifically, increased abundance of both secreted (e.g. α‐toxin, Psms, LukAB, LukE, PVL, Sbi, γ‐hemolysin) and surface‐associated (e.g. ClfA+B, FnbA+B, IsdA, Spa) proteins was observed upon protease deletion. Collectively, our findings provide a unique insight into the progression of CA‐MRSA infections, and the role of secreted proteolytic enzymes. We show here that secreted proteases are major regulators of Staphylococcus aureus infections. They function by not only cleaving self‐derived virulence determinants to control the progression of infection, but possess their own, innate, virulence affecting properties as well. As such, they can be consider key factors in the control of S. aureus disease progression.
Staphylococcus aureus is a highly virulent and successful pathogen that causes a diverse array of diseases. Recently, an increase of severe infections in healthy subjects has been observed, caused by community-associated methicillin-resistant S. aureus (CA-MRSA). The reason for enhanced CA-MRSA virulence is unclear; however, work suggests that it results from hypersecretion of agr -regulated toxins, including secreted proteases. In this study, we explore the contribution of exo-proteases to CA-MRSA pathogenesis using a mutant lacking all 10 enzymes. We show that they are required for growth in peptide-rich environments, serum, in the presence of antimicrobial peptides (AMPs), and in human blood. We also reveal that extracellular proteases are important for resisting phagocytosis by human leukocytes. Using murine infection models, we reveal contrasting roles for the proteases in morbidity and mortality. Upon exo-protease deletion, we observed decreases in abscess formation, and impairment during organ invasion. In contrast, we observed hypervirulence of the protease-null strain in the context of mortality. This dichotomy is explained by proteomic analyses, which demonstrates exo-proteases to be key mediators of virulence-determinant stability. Specifically, increased abundance of both secreted (e.g. α-toxin, Psms, LukAB, LukE, PVL, Sbi, γ-hemolysin) and surface-associated (e.g. ClfA+B, FnbA+B, IsdA, Spa) proteins was observed upon protease deletion. Collectively, our findings provide a unique insight into the progression of CA-MRSA infections, and the role of secreted proteolytic enzymes.
Staphylococcus aureus is a highly virulent and successful pathogen that causes a diverse array of diseases. Recently, an increase of severe infections in healthy subjects has been observed, caused by community-associated methicillin-resistant S. aureus (CA-MRSA). The reason for enhanced CA-MRSA virulence is unclear; however, work suggests that it results from hypersecretion of agr-regulated toxins, including secreted proteases. In this study, we explore the contribution of exo-proteases to CA-MRSA pathogenesis using a mutant lacking all 10 enzymes. We show that they are required for growth in peptide-rich environments, serum, in the presence of antimicrobial peptides (AMPs), and in human blood. We also reveal that extracellular proteases are important for resisting phagocytosis by human leukocytes. Using murine infection models, we reveal contrasting roles for the proteases in morbidity and mortality. Upon exo-protease deletion, we observed decreases in abscess formation, and impairment during organ invasion. In contrast, we observed hypervirulence of the protease-null strain in the context of mortality. This dichotomy is explained by proteomic analyses, which demonstrates exo-proteases to be key mediators of virulence-determinant stability. Specifically, increased abundance of both secreted (e.g. α-toxin, Psms, LukAB, LukE, PVL, Sbi, γ-hemolysin) and surface-associated (e.g. ClfA+B, FnbA+B, IsdA, Spa) proteins was observed upon protease deletion. Collectively, our findings provide a unique insight into the progression of CA-MRSA infections, and the role of secreted proteolytic enzymes.
Author Mootz, Joe M.
Kolar, Stacey L.
Rivera, Frances E.
Horswill, Alexander R.
Shaw, Lindsey N.
Davenport, Jessica E.
Antonio Ibarra, J.
Stevens, Stanley M.
Author_xml – sequence: 1
  givenname: Stacey L.
  surname: Kolar
  fullname: Kolar, Stacey L.
  organization: University of South Florida
– sequence: 2
  givenname: J.
  surname: Antonio Ibarra
  fullname: Antonio Ibarra, J.
  organization: University of Iowa
– sequence: 3
  givenname: Frances E.
  surname: Rivera
  fullname: Rivera, Frances E.
  organization: University of South Florida
– sequence: 4
  givenname: Joe M.
  surname: Mootz
  fullname: Mootz, Joe M.
  organization: University of Iowa
– sequence: 5
  givenname: Jessica E.
  surname: Davenport
  fullname: Davenport, Jessica E.
  organization: University of South Florida
– sequence: 6
  givenname: Stanley M.
  surname: Stevens
  fullname: Stevens, Stanley M.
  organization: University of South Florida
– sequence: 7
  givenname: Alexander R.
  surname: Horswill
  fullname: Horswill, Alexander R.
  organization: University of Iowa
– sequence: 8
  givenname: Lindsey N.
  surname: Shaw
  fullname: Shaw, Lindsey N.
  organization: University of South Florida
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23233325$$D View this record in MEDLINE/PubMed
BookMark eNpVkU1vFDEMhiNURD-o-AcoRyS0JZ8zmQsSrVpAKuoBOEeZjGc3kEmWJFOYG3cu_EZ-CVm1rIovtuTHr2W_x-ggxAAIPaPkjBLCXk195GdSPkJHjAi5Uoq1Bw_qQ3Sa8xdSoyWsEfQJOmSccc6ZPEK_Ln-UZCx4P3uT8DbFAiZDxiYB_goLnmBwpsSUcRzxx2K2m8VHG62dKzMnqOnWpdlDsFArg8sG8NrH3ng8xaGqFhfDbniP_fn5e4ACaXLBhIJzMb3zrixP0ePR-Ayn9_kEfb66_HTxbnV98_b9xZvr1Zo3XK6anpKuN0K2Somub0VnBkEMjGNHxGjH3khOm05J0jay5eNg5SgHkEIN3DZE8hP0-k53O_f1PAuhvsDrbXKTSYuOxun_O8Ft9Dreai6VYJRWgRf3Ail-myEXPbm8-6EJEOesKVOKU0obXtHnD3ftl_xzoAIv74DvzsOy71Oid97qnbdaSv3h_IZLyf8CXU-dQA
ContentType Journal Article
Copyright 2012 The Authors. published by Blackwell Publishing Ltd.
2012 The Authors. Published by Blackwell Publishing Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Copyright © 2012 Published by Blackwell Publishing Ltd. 2012
Copyright_xml – notice: 2012 The Authors. published by Blackwell Publishing Ltd.
– notice: 2012 The Authors. Published by Blackwell Publishing Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
– notice: Copyright © 2012 Published by Blackwell Publishing Ltd. 2012
DBID 24P
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1002/mbo3.55
DatabaseName Wiley Online Library Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-8827
EndPage 34
ExternalDocumentID PMC3584211
23233325
MBO355
Genre article
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: National Institute of Allergies and Infectious Diseases
– fundername: NIAID NIH HHS
  grantid: R01 AI078921
– fundername: NIAID NIH HHS
  grantid: AI078921
– fundername: NIAID NIH HHS
  grantid: R21 AI090350
– fundername: NIAID NIH HHS
  grantid: AI090350
GroupedDBID 0R~
1OC
24P
53G
5VS
7X7
8-0
8-1
8FE
8FH
8FI
8FJ
AAHHS
AAKDD
AAZKR
ABUWG
ACCFJ
ACCMX
ACGFO
ACPRK
ACXQS
ADBBV
ADKYN
ADRAZ
ADZMN
AEEZP
AEGXH
AENEX
AEQDE
AEUYN
AFKRA
AFRAH
AHMBA
AIAGR
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
D-8
D-9
DIK
EBD
EBS
EJD
EMOBN
FYUFA
GODZA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
HZ~
IAO
IGS
IHR
INH
ITC
KQ8
LK8
M48
M7P
M~E
O9-
OK1
PIMPY
PQQKQ
PROAC
RPM
SV3
UKHRP
WIN
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
PHGZM
PHGZT
PQGLB
7X8
5PM
ID FETCH-LOGICAL-g3635-6b109ba4578849b749ad40aeff904fcfba5316985076573fdc5f5de548d3c6053
IEDL.DBID M48
ISSN 2045-8827
IngestDate Thu Aug 21 18:45:11 EDT 2025
Thu Jul 10 18:32:36 EDT 2025
Mon Jul 21 05:37:27 EDT 2025
Wed Jan 22 16:37:16 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Attribution
2012 The Authors. Published by Blackwell Publishing Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-g3635-6b109ba4578849b749ad40aeff904fcfba5316985076573fdc5f5de548d3c6053
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Funding Information This study was supported in part by grants AI090350 (L. N. S.) and AI078921 (A. R. H.) from the National Institute of Allergies and Infectious Diseases.
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1002/mbo3.55
PMID 23233325
PQID 1288311163
PQPubID 23479
PageCount 17
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3584211
proquest_miscellaneous_1288311163
pubmed_primary_23233325
wiley_primary_10_1002_mbo3_55_MBO355
PublicationCentury 2000
PublicationDate February 2013
PublicationDateYYYYMMDD 2013-02-01
PublicationDate_xml – month: 02
  year: 2013
  text: February 2013
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle MicrobiologyOpen (Weinheim)
PublicationTitleAlternate Microbiologyopen
PublicationYear 2013
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References 2010; 11
2008; 190
2007; 189
2009; 47
2011; 157
2012; 287
2005; 331
2002; 277
2004; 6
1988; 263
2008; 3
2009a; 390
2012; 14
2012; 12
2011; 193
2009; 48
1986; 261
2007; 9
2003; 47
2007; 65
2008; 198
2003; 41
2009; 16
2012; 65
2010; 6
2006; 12
2012
2005; 353
1997; 65
2006; 55
2000; 68
2004; 48
2008; 16
1998; 339
2011; 77
2006; 6
1999; 262
2006
2011; 79
2008; 10
2008; 52
2006; 194
1992; 31
2003; 71
2001; 69
1995; 3
2007; 13
2011; 7
2006; 355
2001; 276
2012; 194
2009; 75
2007; 315
2009; 72
2005; 201
1980; 12
2004; 150
2009b; 1
2009; 9
2008; 46
1999; 76
2002; 70
2005; 3
2008; 410
1998; 30
1992; 60
2003; 187
2006; 188
2011; 186
2009; 106
17496096 - J Bacteriol. 2007 Jul;189(14):5119-29
6785302 - J Clin Microbiol. 1980 Aug;12(2):138-9
17217429 - Cell Microbiol. 2007 May;9(5):1172-90
21478342 - J Bacteriol. 2011 Jun;193(12):2948-58
18585915 - Trends Microbiol. 2008 Aug;16(8):361-9
11399757 - J Biol Chem. 2001 Aug 10;276(32):29969-78
10517329 - Mol Gen Genet. 1999 Sep;262(2):323-31
15897280 - J Exp Med. 2005 May 16;201(10):1669-76
16470658 - Proteomics. 2006 Mar;6(5):1530-49
10532376 - Antonie Van Leeuwenhoek. 1999 Jul-Nov;76(1-4):139-55
17608791 - Mol Microbiol. 2007 Aug;65(3):780-98
18205806 - FEMS Immunol Med Microbiol. 2008 Mar;52(2):267-72
18266611 - Clin Infect Dis. 2008 Mar 15;46(6):787-94
21502375 - J Immunol. 2011 Jun 1;186(11):6445-53
18598194 - J Infect Dis. 2008 Aug 15;198(4):561-70
19286789 - Appl Environ Microbiol. 2009 May;75(10):3355-7
19400778 - Mol Microbiol. 2009 May;72(4):947-63
9199429 - Infect Immun. 1997 Jul;65(7):2621-8
11447146 - Infect Immun. 2001 Aug;69(8):4742-8
14702415 - Microbiology. 2004 Jan;150(Pt 1):217-28
16051359 - Plasmid. 2006 Jan;55(1):58-63
19050758 - PLoS One. 2008;3(12):e3844
19321725 - J Clin Microbiol. 2009 May;47(5):1344-51
11179322 - Infect Immun. 2001 Mar;69(3):1521-7
20072612 - PLoS Pathog. 2010 Jan;6(1):e1000715
19137654 - Clin Infect Dis. 2009 Feb 1;48(3):274-84
11119502 - Infect Immun. 2001 Jan;69(1):159-69
16672616 - J Bacteriol. 2006 May;188(10):3622-30
11035746 - Infect Immun. 2000 Nov;68(11):6362-9
1372285 - Immunol Lett. 1992 Feb 15;31(3):259-65
18064027 - Nat Med. 2007 Dec;13(12):1405-6
17109350 - J Infect Dis. 2006 Dec 15;194(12):1761-70
22685284 - J Bacteriol. 2012 Aug;194(16):4342-54
16210260 - BMJ. 2005 Oct 8;331(7520):793-4
17994102 - Nat Med. 2007 Dec;13(12):1510-4
21255120 - Mol Microbiol. 2011 Feb;79(3):814-25
21784926 - J Bacteriol. 2011 Oct;193(19):5279-91
19759252 - Clin Vaccine Immunol. 2009 Nov;16(11):1607-14
3422637 - J Biol Chem. 1988 Feb 25;263(6):2664-7
1612733 - Infect Immun. 1992 Jul;60(7):2636-40
17953091 - Emerg Infect Dis. 2007 Aug;13(8):1195-200
9791183 - Mol Microbiol. 1998 Oct;30(2):393-404
18223088 - J Bacteriol. 2008 Apr;190(7):2253-6
12636257 - Microbiol Immunol. 2003;47(1):81-90
16177250 - N Engl J Med. 2005 Sep 22;353(12):1245-51
18632911 - J Clin Microbiol. 2008 Sep;46(9):2837-41
11447207 - Infect Immun. 2001 Aug;69(8):5198-202
10816507 - Infect Immun. 2000 Jun;68(6):3523-34
18715285 - Cell Microbiol. 2008 Nov;10(11):2312-25
16704793 - Emerg Infect Dis. 2006 Mar;12(3):498-500
18183290 - PLoS One. 2008;3(1):e1409
14605147 - J Clin Microbiol. 2003 Nov;41(11):5113-20
19587839 - J Biol Dyn. 2010 Jan;4(1):115-29
15561843 - Antimicrob Agents Chemother. 2004 Dec;48(12):4673-9
12117932 - Infect Immun. 2002 Aug;70(8):4239-46
22028651 - PLoS Pathog. 2011 Oct;7(10):e1002307
19284294 - Biol Chem. 2009 Apr;390(4):361-71
22371493 - J Biol Chem. 2012 Apr 20;287(17):13889-98
12654843 - Infect Immun. 2003 Apr;71(4):2208-17
22309135 - FEMS Immunol Med Microbiol. 2012 Jun;65(1):5-22
22613209 - Microbes Infect. 2012 Sep;14(11):989-99
19293374 - Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5883-8
22106056 - Proteomics. 2012 Jan;12(2):263-8
21926198 - Appl Environ Microbiol. 2011 Nov;77(22):8097-105
17973626 - Biochem J. 2008 Feb 15;410(1):157-65
12552423 - J Infect Dis. 2003 Feb 1;187(3):398-407
19726228 - Curr Opin Pharmacol. 2009 Oct;9(5):545-51
20078865 - BMC Genomics. 2010;11:36
15703760 - Nat Rev Microbiol. 2005 Mar;3(3):238-50
17234914 - Science. 2007 Feb 23;315(5815):1130-3
20375568 - J Innate Immun. 2009;1(2):98-108
8564361 - Trends Microbiol. 1995 Oct;3(10):405-7
12207024 - J Biol Chem. 2002 Nov 1;277(44):41770-7
3533918 - J Biol Chem. 1986 Oct 25;261(30):14330-4
21565927 - Microbiology. 2011 Aug;157(Pt 8):2206-19
14998519 - Microbes Infect. 2004 Feb;6(2):202-6
22850671 - EMBO J. 2012 Aug 29;31(17):3607-19
16914702 - N Engl J Med. 2006 Aug 17;355(7):666-74
9709046 - N Engl J Med. 1998 Aug 20;339(8):520-32
References_xml – volume: 77
  start-page: 8097
  year: 2011
  end-page: 8105
  article-title: Expression of virulence factors by grown in serum
  publication-title: Appl. Environ. Microbiol.
– volume: 65
  start-page: 2621
  year: 1997
  end-page: 2628
  article-title: Modification of the fibronectin binding phenotype by V8 protease
  publication-title: Infect. Immun.
– volume: 315
  start-page: 1130
  year: 2007
  end-page: 1133
  article-title: Panton‐Valentine leukocidin causes necrotizing pneumonia
  publication-title: Science
– volume: 339
  start-page: 520
  year: 1998
  end-page: 532
  article-title: infections
  publication-title: N. Engl. J. Med.
– volume: 3
  start-page: 238
  year: 2005
  end-page: 250
  article-title: Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
  publication-title: Nat. Rev. Microbiol.
– volume: 76
  start-page: 139
  year: 1999
  end-page: 155
  article-title: Multi‐domain, cell‐envelope proteinases of lactic acid bacteria
  publication-title: Antonie Van Leeuwenhoek
– volume: 70
  start-page: 4239
  year: 2002
  end-page: 4246
  article-title: Variation in extracellular protease production among clinical isolates of due to different levels of expression of the protease repressor
  publication-title: Infect. Immun.
– volume: 9
  start-page: 545
  year: 2009
  end-page: 551
  article-title: An update on community‐associated MRSA virulence
  publication-title: Curr. Opin. Pharmacol.
– volume: 193
  start-page: 2948
  year: 2011
  end-page: 2958
  article-title: Defining the strain‐dependent impact of the Staphylococcal accessory regulator ( ) on the alpha‐toxin phenotype of
  publication-title: J. Bacteriol.
– volume: 106
  start-page: 5883
  year: 2009
  end-page: 5888
  article-title: Evolution of virulence in epidemic community‐associated methicillin‐resistant
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 12
  start-page: 263
  year: 2012
  end-page: 268
  article-title: The impact of CodY on virulence determinant production in community‐associated methicillin‐resistant
  publication-title: Proteomics
– volume: 13
  start-page: 1405
  year: 2007
  end-page: 1406
  article-title: Poring over pores: alpha‐hemolysin and Panton‐Valentine leukocidin in pneumonia
  publication-title: Nat. Med.
– volume: 261
  start-page: 14330
  year: 1986
  end-page: 14334
  article-title: The inactivation of human plasma alpha 1‐proteinase inhibitor by proteinases from
  publication-title: J. Biol. Chem.
– volume: 46
  start-page: 2837
  year: 2008
  end-page: 2841
  article-title: Characterization of isolates from nasal cultures collected from individuals in the United States in 2001 to 2004
  publication-title: J. Clin. Microbiol.
– volume: 1
  start-page: 98
  year: 2009b
  end-page: 108
  article-title: A new pathway of staphylococcal pathogenesis: apoptosis‐like death induced by Staphopain B in human neutrophils and monocytes
  publication-title: J. Innate Immun.
– volume: 13
  start-page: 1195
  year: 2007
  end-page: 1200
  article-title: Skin and soft tissue infections caused by methicillin‐resistant USA300 clone
  publication-title: Emerg. Infect. Dis.
– volume: 390
  start-page: 361
  year: 2009a
  end-page: 371
  article-title: Staphylococcal cysteine protease staphopain B (SspB) induces rapid engulfment of human neutrophils and monocytes by macrophages
  publication-title: Biol. Chem.
– volume: 47
  start-page: 1344
  year: 2009
  end-page: 1351
  article-title: Characterization of methicillin‐resistant isolates collected in 2005 and 2006 from patients with invasive disease: a population‐based analysis
  publication-title: J. Clin. Microbiol.
– volume: 30
  start-page: 393
  year: 1998
  end-page: 404
  article-title: genetic loci impacting growth and survival in multiple infection environments
  publication-title: Mol. Microbiol.
– volume: 6
  start-page: 1530
  year: 2006
  end-page: 1549
  article-title: Proteomic profiling of cell envelope‐associated proteins from
  publication-title: Proteomics
– volume: 287
  start-page: 13889
  year: 2012
  end-page: 13898
  article-title: Novel phenol‐soluble modulin derivatives in community‐associated methicillin‐resistant identified through imaging mass spectrometry
  publication-title: J. Biol. Chem.
– volume: 55
  start-page: 58
  year: 2006
  end-page: 63
  article-title: Allelic replacement in with inducible counter‐selection
  publication-title: Plasmid
– volume: 188
  start-page: 3622
  year: 2006
  end-page: 3630
  article-title: Cation‐induced transcriptional regulation of the operon of
  publication-title: J. Bacteriol.
– volume: 331
  start-page: 793
  year: 2005
  end-page: 794
  article-title: , Panton‐Valentine leukocidin, and necrotising pneumonia
  publication-title: BMJ
– volume: 46
  start-page: 787
  year: 2008
  end-page: 794
  article-title: Are community‐associated methicillin‐resistant (MRSA) strains replacing traditional nosocomial MRSA strains?
  publication-title: Clin. Infect. Dis.
– volume: 71
  start-page: 2208
  year: 2003
  end-page: 2217
  article-title: as a model host for pathogenesis
  publication-title: Infect. Immun.
– volume: 72
  start-page: 947
  year: 2009
  end-page: 963
  article-title: Characterization of staphyloferrin A biosynthetic and transport mutants in
  publication-title: Mol. Microbiol.
– volume: 52
  start-page: 267
  year: 2008
  end-page: 272
  article-title: infection triggers production of neutralizing, V8 protease‐specific antibodies
  publication-title: FEMS Immunol. Med. Microbiol.
– volume: 410
  start-page: 157
  year: 2008
  end-page: 165
  article-title: The human fibrinolytic system is a target for the staphylococcal metalloprotease aureolysin
  publication-title: Biochem. J.
– volume: 277
  start-page: 41770
  year: 2002
  end-page: 41777
  article-title: Identification of a novel maturation mechanism and restricted substrate specificity for the SspB cysteine protease of
  publication-title: J. Biol. Chem.
– volume: 14
  start-page: 989
  year: 2012
  end-page: 999
  article-title: Identification of an intracellular M17 family leucine aminopeptidase that is required for virulence in
  publication-title: Microbes Infect.
– start-page: 496
  year: 2006
  end-page: 516
– volume: 6
  start-page: 202
  year: 2004
  end-page: 206
  article-title: Impact of staphylococcal protease expression on the outcome of infectious arthritis
  publication-title: Microbes Infect.
– volume: 198
  start-page: 561
  year: 2008
  end-page: 570
  article-title: Comparison of virulence in community‐associated methicillin‐resistant pulsotypes USA300 and USA400 in a rat model of pneumonia
  publication-title: J. Infect. Dis.
– volume: 60
  start-page: 2636
  year: 1992
  end-page: 2640
  article-title: Murine model of cutaneous infection with Gram‐positive cocci
  publication-title: Infect. Immun.
– volume: 79
  start-page: 814
  year: 2011
  end-page: 825
  article-title: Characterization of a new cytotoxin that contributes to pathogenesis
  publication-title: Mol. Microbiol.
– volume: 186
  start-page: 6445
  year: 2011
  end-page: 6453
  article-title: metalloprotease aureolysin cleaves complement C3 to mediate immune evasion
  publication-title: J. Immunol.
– volume: 3
  start-page: e3844
  year: 2008
  article-title: Identification and characterization of sigmaS, a novel component of the stress and virulence responses
  publication-title: PLoS ONE
– volume: 353
  start-page: 1245
  year: 2005
  end-page: 1251
  article-title: sepsis and the Waterhouse‐Friderichsen syndrome in children
  publication-title: N. Engl. J. Med.
– volume: 187
  start-page: 398
  year: 2003
  end-page: 407
  article-title: Selective modulation of superantigen‐induced responses by streptococcal cysteine protease
  publication-title: J. Infect. Dis.
– volume: 150
  start-page: 217
  year: 2004
  end-page: 228
  article-title: The role and regulation of the extracellular proteases of
  publication-title: Microbiology
– volume: 3
  start-page: 405
  year: 1995
  end-page: 407
  article-title: Are bacterial proteinases pathogenic factors?
  publication-title: Trends Microbiol.
– volume: 201
  start-page: 1669
  year: 2005
  end-page: 1676
  article-title: Induction of vascular leakage through release of bradykinin and a novel kinin by cysteine proteinases from
  publication-title: J. Exp. Med.
– volume: 69
  start-page: 159
  year: 2001
  end-page: 169
  article-title: Description of staphylococcus serine protease ( ) operon in and nonpolar inactivation of ‐encoded serine protease
  publication-title: Infect. Immun.
– volume: 31
  start-page: 259
  year: 1992
  end-page: 265
  article-title: Cleavage of human immunoglobulins by serine proteinase from
  publication-title: Immunol. Lett.
– volume: 68
  start-page: 6362
  year: 2000
  end-page: 6369
  article-title: Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases
  publication-title: Infect. Immun.
– volume: 193
  start-page: 5279
  year: 2011
  end-page: 5291
  article-title: Proteolytic cleavage inactivates the lipoteichoic acid synthase
  publication-title: J. Bacteriol.
– volume: 16
  start-page: 361
  year: 2008
  end-page: 369
  article-title: The role of virulence determinants in community‐associated MRSA pathogenesis
  publication-title: Trends Microbiol.
– volume: 194
  start-page: 4342
  year: 2012
  end-page: 4354
  article-title: The Extracytoplasmic Function Sigma Factor sigmaS Protects against both Intracellular and Extracytoplasmic Stresses in
  publication-title: J. Bacteriol.
– volume: 263
  start-page: 2664
  year: 1988
  end-page: 2667
  article-title: Degradation of elastin by a cysteine proteinase from
  publication-title: J. Biol. Chem.
– volume: 189
  start-page: 5119
  year: 2007
  end-page: 5129
  article-title: Only one of four oligopeptide transport systems mediates nitrogen nutrition in
  publication-title: J. Bacteriol.
– volume: 75
  start-page: 3355
  year: 2009
  end-page: 3357
  article-title: Dual role of the oligopeptide permease Opp 3 during growth of Staphylococcus aureus in milk
  publication-title: Appl. Environ. Microbiol.
– volume: 69
  start-page: 4742
  year: 2001
  end-page: 4748
  article-title: Decreased amounts of cell wall‐associated protein A and fibronectin‐binding proteins in mutants due to up‐regulation of extracellular proteases
  publication-title: Infect. Immun.
– volume: 10
  start-page: 2312
  year: 2008
  end-page: 2325
  article-title: A novel vertebrate model of infection reveals phagocyte‐dependent resistance of zebrafish to non‐host specialized pathogens
  publication-title: Cell. Microbiol.
– volume: 41
  start-page: 5113
  year: 2003
  end-page: 5120
  article-title: Pulsed‐field gel electrophoresis typing of oxacillin‐resistant isolates from the United States: establishing a national database
  publication-title: J. Clin. Microbiol.
– volume: 13
  start-page: 1510
  year: 2007
  end-page: 1514
  article-title: Identification of novel cytolytic peptides as key virulence determinants for community‐associated MRSA
  publication-title: Nat. Med.
– volume: 69
  start-page: 5198
  year: 2001
  end-page: 5202
  article-title: Identification and analysis of components expressed by a model system of growth in serum
  publication-title: Infect. Immun.
– volume: 16
  start-page: 1607
  year: 2009
  end-page: 1614
  article-title: Human immune proteome in experimental colonization with
  publication-title: Clin. Vaccine Immunol.
– volume: 12
  start-page: 498
  year: 2006
  end-page: 500
  article-title: Pneumonia and new methicillin‐resistant clone
  publication-title: Emerg. Infect. Dis.
– volume: 355
  start-page: 666
  year: 2006
  end-page: 674
  article-title: Methicillin‐resistant infections among patients in the emergency department
  publication-title: N. Engl. J. Med.
– volume: 194
  start-page: 1761
  year: 2006
  end-page: 1770
  article-title: Is Panton‐Valentine leukocidin the major virulence determinant in community‐associated methicillin‐resistant disease?
  publication-title: J. Infect. Dis.
– volume: 68
  start-page: 3523
  year: 2000
  end-page: 3534
  article-title: Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases
  publication-title: Infect. Immun.
– volume: 69
  start-page: 1521
  year: 2001
  end-page: 1527
  article-title: Molecular characterization of a novel serine protease operon
  publication-title: Infect. Immun.
– volume: 65
  start-page: 5
  year: 2012
  end-page: 22
  article-title: Virulence strategies of the dominant USA300 lineage of community‐associated methicillin‐resistant (CA‐MRSA)
  publication-title: FEMS Immunol. Med. Microbiol.
– volume: 47
  start-page: 81
  year: 2003
  end-page: 90
  article-title: Purification, cloning and characterization of variant LukE‐LukD with strong leukocidal activity of staphylococcal bi‐component leukotoxin family
  publication-title: Microbiol. Immunol.
– volume: 48
  start-page: 271
  year: 2009
  article-title: Competition of hospital‐acquired and community‐acquired methicillin‐resistant strains in hospitals
  publication-title: J. Biol. Dyn.
– volume: 12
  start-page: 138
  year: 1980
  end-page: 139
  article-title: Prothrombin activation by a metalloprotease from
  publication-title: J. Clin. Microbiol.
– volume: 3
  start-page: e1409
  year: 2008
  article-title: A potential new pathway for dissemination: the silent survival of phagocytosed by human monocyte‐derived macrophages
  publication-title: PLoS ONE
– volume: 262
  start-page: 323
  year: 1999
  end-page: 331
  article-title: Interactive regulatory pathways control virulence determinant production and stability in response to environmental conditions in
  publication-title: Mol. Gen. Genet.
– volume: 157
  start-page: 2206
  year: 2011
  end-page: 2219
  article-title: NsaRS is a cell‐envelope‐stress‐sensing two‐component system of
  publication-title: Microbiology
– volume: 6
  start-page: e1000715
  year: 2010
  article-title: panton‐valentine leukocidin is a very potent cytotoxic factor for human neutrophils
  publication-title: PLoS Pathog.
– volume: 9
  start-page: 1172
  year: 2007
  end-page: 1190
  article-title: Global analysis of community‐associated methicillin‐resistant exoproteins reveals molecules produced in vitro and during infection
  publication-title: Cell. Microbiol.
– volume: 65
  start-page: 780
  year: 2007
  end-page: 798
  article-title: A role for type I signal peptidase in quorum sensing
  publication-title: Mol. Microbiol.
– year: 2012
  article-title: Staphopain A inhibits CXCR2‐dependent neutrophil activation and chemotaxis
  publication-title: EMBO J
– volume: 276
  start-page: 29969
  year: 2001
  end-page: 29978
  article-title: Loss of clumping factor B fibrinogen binding activity by involves cessation of transcription, shedding and cleavage by metalloprotease
  publication-title: J. Biol. Chem.
– volume: 48
  start-page: 4673
  year: 2004
  end-page: 4679
  article-title: Degradation of human antimicrobial peptide LL‐37 by ‐derived proteinases
  publication-title: Antimicrob. Agents Chemother.
– volume: 7
  start-page: e1002307
  year: 2011
  article-title: Preventing sepsis through the inhibition of its agglutination in blood
  publication-title: PLoS Pathog.
– volume: 11
  start-page: 36
  year: 2010
  article-title: The proteolytic system of lactic acid bacteria revisited: a genomic comparison
  publication-title: BMC Genomics
– volume: 190
  start-page: 2253
  year: 2008
  end-page: 2256
  article-title: –probing for host weakness?
  publication-title: J. Bacteriol.
– volume: 48
  start-page: 274
  year: 2009
  end-page: 284
  article-title: Modeling the invasion of community‐acquired methicillin‐resistant into hospitals
  publication-title: Clin. Infect. Dis.
– reference: 19050758 - PLoS One. 2008;3(12):e3844
– reference: 3422637 - J Biol Chem. 1988 Feb 25;263(6):2664-7
– reference: 21926198 - Appl Environ Microbiol. 2011 Nov;77(22):8097-105
– reference: 21255120 - Mol Microbiol. 2011 Feb;79(3):814-25
– reference: 18064027 - Nat Med. 2007 Dec;13(12):1405-6
– reference: 1372285 - Immunol Lett. 1992 Feb 15;31(3):259-65
– reference: 18632911 - J Clin Microbiol. 2008 Sep;46(9):2837-41
– reference: 15561843 - Antimicrob Agents Chemother. 2004 Dec;48(12):4673-9
– reference: 12636257 - Microbiol Immunol. 2003;47(1):81-90
– reference: 11447207 - Infect Immun. 2001 Aug;69(8):5198-202
– reference: 20078865 - BMC Genomics. 2010;11:36
– reference: 16914702 - N Engl J Med. 2006 Aug 17;355(7):666-74
– reference: 18598194 - J Infect Dis. 2008 Aug 15;198(4):561-70
– reference: 12207024 - J Biol Chem. 2002 Nov 1;277(44):41770-7
– reference: 22685284 - J Bacteriol. 2012 Aug;194(16):4342-54
– reference: 21565927 - Microbiology. 2011 Aug;157(Pt 8):2206-19
– reference: 17496096 - J Bacteriol. 2007 Jul;189(14):5119-29
– reference: 18223088 - J Bacteriol. 2008 Apr;190(7):2253-6
– reference: 18266611 - Clin Infect Dis. 2008 Mar 15;46(6):787-94
– reference: 22371493 - J Biol Chem. 2012 Apr 20;287(17):13889-98
– reference: 22309135 - FEMS Immunol Med Microbiol. 2012 Jun;65(1):5-22
– reference: 16470658 - Proteomics. 2006 Mar;6(5):1530-49
– reference: 11399757 - J Biol Chem. 2001 Aug 10;276(32):29969-78
– reference: 12552423 - J Infect Dis. 2003 Feb 1;187(3):398-407
– reference: 15897280 - J Exp Med. 2005 May 16;201(10):1669-76
– reference: 9199429 - Infect Immun. 1997 Jul;65(7):2621-8
– reference: 16672616 - J Bacteriol. 2006 May;188(10):3622-30
– reference: 17608791 - Mol Microbiol. 2007 Aug;65(3):780-98
– reference: 11447146 - Infect Immun. 2001 Aug;69(8):4742-8
– reference: 14702415 - Microbiology. 2004 Jan;150(Pt 1):217-28
– reference: 16051359 - Plasmid. 2006 Jan;55(1):58-63
– reference: 19286789 - Appl Environ Microbiol. 2009 May;75(10):3355-7
– reference: 17109350 - J Infect Dis. 2006 Dec 15;194(12):1761-70
– reference: 19587839 - J Biol Dyn. 2010 Jan;4(1):115-29
– reference: 11179322 - Infect Immun. 2001 Mar;69(3):1521-7
– reference: 10816507 - Infect Immun. 2000 Jun;68(6):3523-34
– reference: 21502375 - J Immunol. 2011 Jun 1;186(11):6445-53
– reference: 22028651 - PLoS Pathog. 2011 Oct;7(10):e1002307
– reference: 14605147 - J Clin Microbiol. 2003 Nov;41(11):5113-20
– reference: 8564361 - Trends Microbiol. 1995 Oct;3(10):405-7
– reference: 18715285 - Cell Microbiol. 2008 Nov;10(11):2312-25
– reference: 17973626 - Biochem J. 2008 Feb 15;410(1):157-65
– reference: 12117932 - Infect Immun. 2002 Aug;70(8):4239-46
– reference: 20375568 - J Innate Immun. 2009;1(2):98-108
– reference: 11035746 - Infect Immun. 2000 Nov;68(11):6362-9
– reference: 22106056 - Proteomics. 2012 Jan;12(2):263-8
– reference: 18183290 - PLoS One. 2008;3(1):e1409
– reference: 9709046 - N Engl J Med. 1998 Aug 20;339(8):520-32
– reference: 11119502 - Infect Immun. 2001 Jan;69(1):159-69
– reference: 18205806 - FEMS Immunol Med Microbiol. 2008 Mar;52(2):267-72
– reference: 1612733 - Infect Immun. 1992 Jul;60(7):2636-40
– reference: 19321725 - J Clin Microbiol. 2009 May;47(5):1344-51
– reference: 19759252 - Clin Vaccine Immunol. 2009 Nov;16(11):1607-14
– reference: 14998519 - Microbes Infect. 2004 Feb;6(2):202-6
– reference: 17217429 - Cell Microbiol. 2007 May;9(5):1172-90
– reference: 19137654 - Clin Infect Dis. 2009 Feb 1;48(3):274-84
– reference: 22613209 - Microbes Infect. 2012 Sep;14(11):989-99
– reference: 15703760 - Nat Rev Microbiol. 2005 Mar;3(3):238-50
– reference: 6785302 - J Clin Microbiol. 1980 Aug;12(2):138-9
– reference: 10532376 - Antonie Van Leeuwenhoek. 1999 Jul-Nov;76(1-4):139-55
– reference: 22850671 - EMBO J. 2012 Aug 29;31(17):3607-19
– reference: 19284294 - Biol Chem. 2009 Apr;390(4):361-71
– reference: 16177250 - N Engl J Med. 2005 Sep 22;353(12):1245-51
– reference: 16704793 - Emerg Infect Dis. 2006 Mar;12(3):498-500
– reference: 10517329 - Mol Gen Genet. 1999 Sep;262(2):323-31
– reference: 19726228 - Curr Opin Pharmacol. 2009 Oct;9(5):545-51
– reference: 16210260 - BMJ. 2005 Oct 8;331(7520):793-4
– reference: 20072612 - PLoS Pathog. 2010 Jan;6(1):e1000715
– reference: 9791183 - Mol Microbiol. 1998 Oct;30(2):393-404
– reference: 19293374 - Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5883-8
– reference: 17953091 - Emerg Infect Dis. 2007 Aug;13(8):1195-200
– reference: 21784926 - J Bacteriol. 2011 Oct;193(19):5279-91
– reference: 3533918 - J Biol Chem. 1986 Oct 25;261(30):14330-4
– reference: 17234914 - Science. 2007 Feb 23;315(5815):1130-3
– reference: 21478342 - J Bacteriol. 2011 Jun;193(12):2948-58
– reference: 17994102 - Nat Med. 2007 Dec;13(12):1510-4
– reference: 18585915 - Trends Microbiol. 2008 Aug;16(8):361-9
– reference: 19400778 - Mol Microbiol. 2009 May;72(4):947-63
– reference: 12654843 - Infect Immun. 2003 Apr;71(4):2208-17
SSID ssj0000702641
Score 2.3242896
Snippet Staphylococcus aureus is a highly virulent and successful pathogen that causes a diverse array of diseases. Recently, an increase of severe infections in...
Staphylococcus aureus is a highly virulent and successful pathogen that causes a diverse array of diseases. Recently, an increase of severe infections in...
SourceID pubmedcentral
proquest
pubmed
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 18
SubjectTerms Animals
Culture Media - chemistry
Disease Models, Animal
Female
Gene Knockout Techniques
Humans
Leukocytes - immunology
Leukocytes - microbiology
Methicillin-Resistant Staphylococcus aureus - enzymology
Methicillin-Resistant Staphylococcus aureus - growth & development
Methicillin-Resistant Staphylococcus aureus - metabolism
Methicillin-Resistant Staphylococcus aureus - pathogenicity
Mice
Original Research
Pathogenesis
Peptide Hydrolases - genetics
Peptide Hydrolases - metabolism
Phagocytosis
protease
Protein Stability
Proteolysis
Staphylococcal Infections - microbiology
Staphylococcal Infections - pathology
Survival Analysis
Virulence
virulence determinant
Virulence Factors - genetics
Virulence Factors - metabolism
SummonAdditionalLinks – databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV07T8MwELagCIkF8Sa8ZCTW0DS2EzICAlVIBQYqdYvs2AYGEtQ2iG7sLPxGfgl3TgitYGBKlNxlsH2-75y77wg5YnEsjImtL7lSPhIq-VIL6St4HiUm0VmI1ci966jb51cDMZhq9VXxQzQHbmgZbr9GA5dq1P4hDX1SBTsWYp4sYGEt0uaH_LY5XoGVDK4ewy3kW_cBR8ZVySxqt2vdv1Dl7-TIadDqvM7lClmu4SI9reZ3lcyZfI0sVg0kJ-vk_eIVtPHwHbNJqSNdALc0onJoKJgndYUh2FCHFpYCsIRBBe9VZFkJMuXQwOXlcVi6yiO4kxTwIK1IQuhToeveXqjciH2-feifHBoK6NLl1042SP_y4u6869ftFfx7BjDDj1QnSJTkYLMnPFExT6TmgTTWJgG3mVUS7DNKTgAxRiJmVmfCCm0gxNEsgyiIbZJWXuRmm1D8exloEykbGG4thEmALK2GULNjI_iyRw6_BzqF5YvDInNTlKO0g92OYb-NmEe2qoFPnyuejRTAHmMsFB6JZ6akEUBq7Nk3-eODo8hmgKsgtPXIkZu8RqMiaQ5TXACpEGnv7AYA187_xHbJUuiaYWAyyx5pjYel2QdIMlYHbvF9AZIk5AM
  priority: 102
  providerName: Wiley-Blackwell
Title Extracellular proteases are key mediators of Staphylococcus aureus virulence via the global modulation of virulence‐determinant stability
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmbo3.55
https://www.ncbi.nlm.nih.gov/pubmed/23233325
https://www.proquest.com/docview/1288311163
https://pubmed.ncbi.nlm.nih.gov/PMC3584211
Volume 2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Na9wwEB3yQaGX0vQr249FhVydei3Jig-lNGVDKGwaShf2ZiRLagONnXrjkv0J_dd9kp1NQnPoxTa2ZMxIY72xZ94j2uNKSeeUT7QwJgmESom2UicG5_PCFbbKQjXy7CQ_novPC7nYoGuVzsGAy3tDu6AnNW9_7l_9Wn2Aw78fCETfnZuG70u5SdtYjlTwztmA8ePrWCHMiAqWgXk9AaJUffHs7b734ct_0yRvw9e4_hw9pkcDcGQf-5HeoQ1XP6EHvZTk6in9mV6hd_gMH_JKWaRfwAK1ZLp1DI7KYolIkNZhjWeAmDAv1rGmqjq06VqH3e-ztos1SDjSDMiQ9XQh7Lyxg8pX6LxultibXBoGlBnzbFfPaH40_fbpOBlkFpLvHHAjyc0kLYwW8N0DURglCm1Fqp33RSp85Y2Gn-bFAZBjLhX3tpJeWodQx_IK0RB_Tlt1U7tdYuEvZmpdbnzqhPcIl4AwvUXIOfE57jyit9dmLjGNg1F07ZpuWU6C6jHeuzkf0Yve7OVFz7dRAvRxzjM5InVnQNYNAkX23Sv12Y9Ilc2BrxDijmgvDt26R0_WnJVh-Espy9nhFwCvl__xeK_oYRYVMUJGy2vaumw79wa45NKMaTMTp9iqhRrT9uH05PTrOMb44zgj_wKFqOsO
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9wwEB7RRVV7qaDPbYEaiWtKNn6EHClitdBdymGRuEV2bLccSKrdTVVuvffCb-SXMOOELKv20FOixJPD2GN_M5n5BmCPp6l0LvWRFsZERKgUaSt1ZPC5ylxmi4SqkSdnanQhTi_lZZtVSbUwDT9EF3Ajywj7NRk4BaT3l6yh16bin6R8AutCJSkZZSLOu_gKLmU868nfIsL1CIFk2tTMkvR-K_svWPl3duRj1BqOneEGvGjxIjtsJngT1lz5Ep42HSRvXsGf418oTdF3SidlgXUBz6U50zPH0D5ZqAyhjjqs8gyRJWoVj6-qKGocU88cXn5ezepQeoR3miEgZA1LCLuubNvci4S7YXe_b-0yiYYhvAwJtjev4WJ4PD0aRW1_hegbR5wRKTOIM6MFGu2ByEwqMm1FrJ33WSx84Y1GA1XZAUJGJVPubSG9tA59HMsLdIP4G-iVVeneAaPfl7F1yvjYCe_RT0Jo6S36mgOv8Mt92H1QdI7rl9SiS1fV83xA7Y5xw1W8D28bxec_GqKNHNEe5zyRfUhXpqQbQNzYq2_Kq--BI5sjsELftg97YfI6iYalOclpAeRS5pPPXxFxvf-_YR_h2Wg6Gefjk7MvH-B5EjpjUGbLFvQWs9ptIz5ZmJ2wEO8B3EDnbw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1NT9wwEB21IFAvFf2i21IwEtdAdh0n5AgtK1oK9MAi1Etkx3bLgQQtpCq33nvpb-SX9I0TAqgcekqUzORgz3jeOOM3RGsyy5RzmY90YkzEhEqRtkpHBs_T3OW2HPFp5P2DdHeSfDpRJ3dafbX8EP2GG3tGWK_Zwc-t37glDT0ztVxX6jHNMkceDHp263jyddJvsMCWEew54WLG9QhIMmsPzbL-Rqf9EK78tzzyLmwNcWe8QE87wCi22hl-Ro9c9Zzm2haSVy_o985PaPP2O9eTikC7gMB0IfTUCTioCEdDuKWOqL0AtMSwIn7VZdlAppk6XH6cTptw9gh3WgARipYmRJzVtuvuxcq92PWvP_a2ikYAX4YK26uXNBnvHL3fjboGC9E3CaARpWYY50Yn8NrNJDdZkmubxNp5n8eJL73R8NA03wRmTFUmvS2VV9YhybGyRB4kX9FMVVfuNQn-fxlblxofu8R7JErAlt4i2Rz6FF8e0OrNQBcwYB4WXbm6uSiG3O8YK24qB7TYDnxx3jJtFIB7UsqRGlB2b0p6ASbHvv-mOv0eSLIlkBWS2wGthcnrNVqa5lHBBlAoVexvHwJyvfk_sRWa__JhXHz-eLD3lp6MQmcMrmxZopnLaePeAZ9cmuXOEv8C7gToZw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Extracellular+proteases+are+key+mediators+of+Staphylococcus+aureus+virulence+via+the+global+modulation+of+virulence-determinant+stability&rft.jtitle=MicrobiologyOpen+%28Weinheim%29&rft.au=Kolar%2C+Stacey+L&rft.au=Ibarra%2C+J+Antonio&rft.au=Rivera%2C+Frances+E&rft.au=Mootz%2C+Joe+M&rft.date=2013-02-01&rft.issn=2045-8827&rft.eissn=2045-8827&rft.volume=2&rft.issue=1&rft.spage=18&rft_id=info:doi/10.1002%2Fmbo3.55&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-8827&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-8827&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-8827&client=summon